Search research articles
Contact Us
Filters
Showing results (111-120 of 151) with videos related to
Page
of 16
Sort By:
The American Journal of Hospice & Palliative Care
|
May 5, 2018
Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer
David J Bartlett, Daniel S Childs, Carmen Radecki Breitkopf, et al.
Cancer Treatment Reviews
|
June 26, 2021
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
Daniel L Hertz, Daniel S Childs, Susanna B Park, et al.
Comparative and Functional Genomics
|
July 17, 2008
Genetic steps to organ laterality in zebrafish
J N Chen, F van Bebber, A M Goldstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 2024
Neurologic Symptoms After <sup>177</sup>Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
Cancers
|
March 14, 2026
PSA Zero Radiographic Disease Progression on PSMA PET/CT
Ahmed M Mahmoud, Carter Day, Eman E Ahmed, et al.
Gynecologic Oncology
|
January 17, 2017
Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer
John B Liao, Ron E Swensen, Kelsie J Ovenell, et al.
The Prostate
|
October 30, 2023
Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis
Ahmed M Mahmoud, Daniel S Childs, Mohamed E Ahmed, et al.
Annals of Translational Medicine
|
July 21, 2025
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy
Miguel Muniz, Daniel S Childs, Jack Andrews, et al.
Gynecologic Oncology
|
October 3, 2024
Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer
John B Liao, Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, et al.
Frontiers in Oncology
|
July 29, 2024
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <sup>177</sup>Lu-PSMA-617 therapy
Gokce Belge Bilgin, Cem Bilgin, Daniel S Childs, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 151) with videos related to
Sort By:
Page
of 16
The American Journal of Hospice & Palliative Care
|
May 5, 2018
Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer
David J Bartlett, Daniel S Childs, Carmen Radecki Breitkopf, et al.
Cancer Treatment Reviews
|
June 26, 2021
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
Daniel L Hertz, Daniel S Childs, Susanna B Park, et al.
Comparative and Functional Genomics
|
July 17, 2008
Genetic steps to organ laterality in zebrafish
J N Chen, F van Bebber, A M Goldstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 2024
Neurologic Symptoms After <sup>177</sup>Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
Cancers
|
March 14, 2026
PSA Zero Radiographic Disease Progression on PSMA PET/CT
Ahmed M Mahmoud, Carter Day, Eman E Ahmed, et al.
Gynecologic Oncology
|
January 17, 2017
Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer
John B Liao, Ron E Swensen, Kelsie J Ovenell, et al.
The Prostate
|
October 30, 2023
Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis
Ahmed M Mahmoud, Daniel S Childs, Mohamed E Ahmed, et al.
Annals of Translational Medicine
|
July 21, 2025
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy
Miguel Muniz, Daniel S Childs, Jack Andrews, et al.
Gynecologic Oncology
|
October 3, 2024
Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer
John B Liao, Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, et al.
Frontiers in Oncology
|
July 29, 2024
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <sup>177</sup>Lu-PSMA-617 therapy
Gokce Belge Bilgin, Cem Bilgin, Daniel S Childs, et al.
Page
of 16